U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C14H16N2O3
Molecular Weight 260.2884
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NADOXOLOL

SMILES

ONC(=N)CC(O)COC1=C2C=CC=CC2=CC=C1

InChI

InChIKey=UPZVYDSBLFNMLK-UHFFFAOYSA-N
InChI=1S/C14H16N2O3/c15-14(16-18)8-11(17)9-19-13-7-3-5-10-4-1-2-6-12(10)13/h1-7,11,17-18H,8-9H2,(H2,15,16)

HIDE SMILES / InChI

Molecular Formula C14H16N2O3
Molecular Weight 260.2884
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Nadoxolol is a beta-adrenergic blocking agent and an antihypertensive drug.

Approval Year

PubMed

PubMed

TitleDatePubMed
Kinetic resolution of 1-chloro-3-(1-naphthyloxy)-2-propanol, an intermediate in the synthesis of beta-adrenergic receptor blockers.
2003-06
[Acute nadoxolol poisoning. A multicentric study of 35 cases].
1982-05
[Clinical study of a new anti-arrhythmia agent: nadoxolol].
1976-04
Patents

Sample Use Guides

LD50 in mice (mg/kg): 180 i.v.; 1000 orally
Route of Administration: Other
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:13:34 GMT 2025
Edited
by admin
on Mon Mar 31 18:13:34 GMT 2025
Record UNII
SK43HU1689
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LL 1530
Preferred Name English
NADOXOLOL
INN   MI   WHO-DD  
INN  
Official Name English
nadoxolol [INN]
Common Name English
BUTANIMIDAMIDE, N,3-DIHYDROXY-4-(1-NAPHTHALENYLOXY)-
Systematic Name English
NADOXOLOL [MI]
Common Name English
Nadoxolol [WHO-DD]
Common Name English
N,3-DIHYDROXY-4-(1-NAPHTHALENYLOXY)BUTANIMIDAMIDE
Systematic Name English
3-HYDROXY-4-(1-NAPHTHYLOXY)BUTYRAMIDOXIME
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29576
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
Code System Code Type Description
DRUG CENTRAL
1866
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
FDA UNII
SK43HU1689
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
WIKIPEDIA
Nadoxolol
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
EVMPD
SUB09112MIG
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
MERCK INDEX
m1212
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY Merck Index
MESH
C006154
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
RXCUI
31462
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY RxNorm
ChEMBL
CHEMBL357513
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
EPA CompTox
DTXSID90968903
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
INN
3322
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
SMS_ID
100000084409
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
CAS
54063-51-3
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
PUBCHEM
37333
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
NCI_THESAURUS
C90798
Created by admin on Mon Mar 31 18:13:34 GMT 2025 , Edited by admin on Mon Mar 31 18:13:34 GMT 2025
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY